Ahmed Salem, MD, MSc, MBBCH, PhD
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Clinical Demonstrator, Department of Radiology, Faculty of Medicine, The University of Alexandria, Alexandria
General Practitioner, Egypt Ministry of Health, Cairo
Education & Training
Degree-Granting Education
| 2022 | Alexandria University, Alexandria, EG, Diagnostic Radiology, PhD |
| 2015 | Alexandria University, Alexandria, EG, Diagnostic Radiology, Master's Degree |
| 2009 | Alexandria University, Alexandria, EG, MBBCh |
Postgraduate Training
| 2021-2022 | Clinical Fellow, Nuclear Radiology, The University of Utah, Salt Lake City, Utah |
| 2020-2021 | Clinical Fellow, Body Imaging, The University of Utah, Salt Lake City, Utah |
| 2019-2020 | Clinical Fellow, Nuclear Radiology, The University of Utah, Salt Lake City, Utah |
| 2017-2019 | Research Fellow, Nuclear Radiology, Huntsman Cancer Institute - The University of Utah, Salt Lake City, Utah |
| 2016-2017 | Visiting Scholar, Nuclear Radiology, University of Utah, Salt Lake City, Utah |
| 2014-2014 | Clinical Observership, Interventional Radiology, Royal Victoria Hospital, Montreal |
| 2013-2013 | Clinical Observership, Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, New York |
| 2011-2015 | Student - Masters Degree, Diagnostic Radiology, Alexandria University, Alexandria |
| 2011-2015 | Resident, Diagnostic Radiology, Alexandria University, Alexandria |
| 2010-2011 | Intern, Diagnostic Radiology, Alexandria University, Alexandria |
| 2009-2010 | Internship, Virchow Campus Humboldt University, Berlin, Texas |
| 2003-2009 | Undergrad, MBBCh, Alexandria University, Alexandria |
Board Certifications
| 2023 | Advanced Cardiac Life Support (ACLS) |
| 2019 | Basic Life Support (BLS) |
Experience & Service
Academic Appointments
Co-Investigator, Department of Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, 2022 - 2024
Clinical Assistant Professor, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 2022 - 2024
Education Lead, Department of Radiology and Imaging Sciences, The University of Utah, Salt Lake City, UT, 2022 - 2024
Research Associate, Department of Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT, 2017 - 2019
Lecturer, Department of Radiology, Faculty of Medicine, The University of Alexandria University, Alexandria, 2015 - 2016
Assistant Lecturer, Department of Radiology, Faculty of Medicine, The University of Alexandria, Alexandria, 2015 - 2022
Honors & Awards
| 2017 | Certificate of Merit, 103rd Scientific Assembly and Annual Meetings of the Radiologic Society of North America |
| 2017 | Cum Laude, 103rd Scientific Assembly and Annual Meetings of the Radiologic Society of North America |
| 2016 | Ministry of High Education Grant, Egyptian Ministry of Higher Education |
| 2015 | Best International Scientific Publication, Alexandria University |
| 2009 | M.B.B.Ch, Faculty of Med of Medicine, Alexandria University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Salem AE, Shah HR, Covington MF, Koppula BR, Fine GC, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies. Cancers (Basel) 14(23), 2022. e-Pub 2022. PMID: 36497423.
- Salem AE, Fine GC, Covington MF, Koppula BR, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies. Cancers (Basel) 14(12), 2022. e-Pub 2022. PMID: 35740665.
- Wiggins RH, Hoffman JM, Fine GC, Covington MF, Salem AE, Koppula BR, Morton KA. PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681709.
- Covington MF, Koppula BR, Fine GC, Salem AE, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681669.
- Koppula BR, Fine GC, Salem AE, Covington MF, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681647.
- Salem AE, Zaki YH, El-Hussieny G, ElNoueam KI, Shaaban AM, Koppula BR, Bustoros M, Salama M, Elsayes KM, Morton K, Covington MF. An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers (Basel) 13(22), 2021. e-Pub 2021. PMID: 34831006.
- Salem AE, Zaki YH, El-Hussieny G, ElNoueam KI, Shaaban AM, Koppula BR, Yang M, Salama M, Elsayes KM, Covington MF. Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680362.
- Wang, Wu, Kirk, Horn, Salem A, Hoffman, Yap, Sonnen, Towner, Bozza, Rodrigues, Morton. Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain. Am J Nucl Med Mol Imaging 8(2):86 - 99, 2018. e-Pub 2018. PMID: 29755842.
- Salem A, Bahir A, Ross V, Karl M, Louis-Martin B. Retroperitoneal Intranodal Contrast Agent Injection for Lymphangiographic Imaging of the Thoracic Duct in View of Percutaneous Intervention, 2015. e-Pub 2015. PMID: 26314649.
Other Articles
- Fine GC, Covington MF, Koppula BR, Salem AE, Wiggins RH, Hoffman JM, Morton KA PET-CT in Clinical Adult Oncology-VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers (Basel) 14(12), 2022. PMID: 35740501.
- Cai ZJ, Salem AE, Wagner-Bartak NA, Elsayes KM, Negm AS, Rezvani M, Menias CO, Shaaban AM Sciatic foramen anatomy and common pathologies: a pictorial review. Abdom Radiol (NY) 47(1):378-398, 2022. PMID: 34664097.
Book Chapters
- Salem A. In Diagnostic Imaging. In: Gastric Carcinoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Melanoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Esophageal Carcinoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Lymphoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Colon Cancer. Elsevier, 2019.
- Salem A, Rogers. In Diagnostic Imaging. In: Rectal Carcinoma. 2. Elsevier, 2019.
- Salem A, Roger. In Diagnostic Imaging. In: Anal Carcinoma. 2nd. Elsevier, 2019.
Selected Presentations & Talks
International Presentations
- 2023. DOTATE PET/CT Imaging in Prostate cancer: Incidental Observations and Potential Future Applications. Poster. NANETS. Montreal, CA.
- 2021. Unusual sites of prostate cancer recurrence, incidentals, second primary malignancies, physiologic variants, and pitfalls on F-18 Fluciclovine PET/CT-pictorial review. Poster. 106 Scientific Assembly and Annual Meeting of the Radiologic Society of North America. Chicago, US.
- 2019. Sciatic Foramen Lesions: Anatomic Considerations and Pathologic Conditions. Poster. 104 Scientific Assembly and Annual Meeting of the Radiologic Society of North America. Chicago, US.
- 2019. High Grade B-Cell Lymphoma (HGBL) in the Abdomen and Pelvis: What the Radiologist Needs to Know. Invited. European Society of Radiology (ESR 2019). Vienna, AT.
- 2017. Lipopolysaccharide Endotoxemia Results in Secondary Neuroinflammation and Deposition of Amyloid Beta and Phosphorylated Tau in the Rat. Invited. 103rd Scientific Assembly and Annual Meeting. Chicago, US.
- 2017. When the Pathologist Asks, 'Are You Sure You are Biopsying the Liver?' Unusual Hepatic Tumor and Tumor like Conditions: Clinical, Pathological and Imaging Features. Poster. 103rd Scientific Assembly and Annual Meeting. Chicago, US.
- 2017. Multimodality imaging of extra hepatic biliary obstruction: Causes, Clinical Aspects and Imaging Features. Poster. 103rd Scientific Assembly and Annual Meeting. Chicago, US.
- What the Radiologist Needs to Know. Invited. 119 Annual Meeting for the ARRS. Hawaii, US.
Grant & Contract Support
| Date: | 2023 - 2024 |
| Title: | RayzeBio RYZ101-301 (SIRB) >> Phase Ib/III global, randomized, controlled, openlabel trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+), well-differentiated gastronteropancreatic neuroendocrine tumors (GEP-NETs) that have progressed following prior treatment with 177Lu-DOTATATE or 177Lu-DOTATOC (177Lu- DOTATATE/TOC) (ACTION-1) |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | RYZ101-301 |
Patient Reviews
CV information above last modified June 10, 2025